Veradermics (MANE) Accounts Payables (2024 - 2026)

Veradermics (MANE) has 3 years of Accounts Payables data on file, last reported at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $2.1 million, down 5.43% from the prior year.
• Accounts Payables for Q1 2026 stood at $1.1 million, down from $2.1 million in the prior quarter.
• Across five years, Accounts Payables topped out at $2.2 million in Q4 2024 and bottomed at $1.1 million in Q1 2026.
• The 3-year median for Accounts Payables is $2.1 million (2025), against an average of $1.8 million.
• Peak annual rise in Accounts Payables reached 5.43% in 2025, while the deepest fall reached 5.43% in 2025.
• A 3-year view of Accounts Payables shows it stood at $2.2 million in 2024, then declined by 5.43% to $2.1 million in 2025, then plunged by 49.62% to $1.1 million in 2026.
• The last three Accounts Payables figures came in at $1.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.2 million (Q4 2024), per Business Quant data.

Peer Comparison